Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Abeona Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 7 filings
- 6 insiders, $981.0K in total
- Insiders trading
- 6
- Net value
- −$981.0K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Abeona Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Alvino Mark | Director | 62,065 | Sep 1, 2026 | 7 |
| Vazzano Joseph Walter | Chief Financial Officer | 492,079 | Jul 22, 2026 | 7 |
| Seshadri Vishwas | Chief Executive Officer | 1,306,108 | Jul 9, 2026 | 8 |
| O'Malley Brendan M. | SVP, Chief Legal Officer | 427,953 | Jul 9, 2026 | 5 |
| Vasanthavada Madhav | Chief Commercial Officer | 290,623 | Jul 9, 2026 | 5 |
| Alland Leila | Director | 162,614 | Jul 2, 2026 | 3 |
| Silverstein Christine Berni | Director | 119,562 | Jun 15, 2026 | 3 |
| Crombez Eric | Director | 37,313 | May 15, 2026 | 3 |
| Goldan Keith A. | Director | 32,751 | Apr 7, 2026 | 1 |
| Wuchterl Donald A. | Director | 167,935 | Feb 2, 2026 | 2 |
| Amoroso Michael | Director | 217,779 | Jan 27, 2026 | 1 |
| Charles Faith L. | Director | 176,407 | Jan 27, 2026 | 1 |
| Zeiher Bernhardt G | Director | 84,458 | Jan 27, 2026 | 1 |
| Atchinson Robert | 10% Owner | – | May 8, 2024 | 0 |
| Gross Phillip | 10% Owner | – | May 8, 2024 | 0 |
| Adage Capital Management, L.P. | 10% Owner | – | May 8, 2024 | 0 |
| Wider Todd | Director | 16,907 | Sep 28, 2022 | 0 |
| Mann Paul Elliot | Director | 16,907 | Sep 28, 2022 | 0 |
| Carr Edward | Chief Financial Officer | 400,169 | Oct 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2025 (view filing) | Jul 22 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −1.50K | $6.64 | −$9.97K | −0.3%477.7K after | |
| Aug 15, 2025 (view filing) | Aug 15 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −15.0K | $7.36 | −$110.4K | −3.1%462.7K after | |
| Aug 15, 2025 (view filing) | Aug 14 | 1 day | Crombez EricDirector | SSale | −4.72K | $6.93 | −$32.7K | −10.0%42.4K after | |
| Sep 22, 2025 (view filing) | Sep 22 | Same day | O'Malley Brendan M.SVP, Chief Legal Officer | SSale | −688 | $5.43 | −$3.74K | −0.2%360.1K after | |
| Oct 1, 2025 (view filing) | Sep 29 | 2 days | Vazzano Joseph WalterChief Financial Officer | SSale | −9.04K | $5.39 | −$48.7K | −2.0%453.6K after | |
| Oct 1, 2025 (view filing) | Sep 29-30 | 2 days | Seshadri VishwasChief Executive Officer | SSale | −44.3K | $5.31 | −$234.9K | −3.6%1.19M after | 2 lots10b5-1 |
| Oct 1, 2025 (view filing) | Sep 29 | 2 days | O'Malley Brendan M.SVP, Chief Legal Officer | SSale | −9.37K | $5.39 | −$50.5K | −2.6%350.8K after | |
| Oct 16, 2025 (view filing) | Oct 16 | Same day | Seshadri VishwasChief Executive Officer | SSale | −249 | $5.49 | −$1.37K | 0.0%1.19M after | |
| Nov 14, 2025 (view filing) | Nov 13 | 1 day | Alvino MarkDirector | SSale | −15.0K | $4.74 | −$71.1K | −19.4%62.3K after | |
| Dec 29, 2025 (view filing) | Dec 29 | Same day | Seshadri VishwasChief Executive Officer | SSale | −25.0K | $5.31 | −$132.8K | −2.1%1.16M after | 10b5-1 |
| Jan 21, 2026 (view filing) | Jan 21 | Same day | Alvino MarkDirector | SSale | −13.5K | $5.23 | −$70.6K | −21.7%48.8K after | |
| Jan 22, 2026 (view filing) | Jan 22 | Same day | O'Malley Brendan M.SVP, Chief Legal Officer | SSale | −13.6K | $5.33 | −$72.4K | −2.9%451.1K after | |
| Jan 22, 2026 (view filing) | Jan 22 | Same day | Seshadri VishwasChief Executive Officer | SSale | −69.8K | $5.33 | −$372.2K | −4.6%1.46M after | |
| Jan 22, 2026 (view filing) | Jan 22 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −18.7K | $5.33 | −$99.5K | −3.2%568.6K after | |
| Jan 26, 2026 (view filing) | Jan 22 | 4 days | Vasanthavada MadhavChief Commercial Officer | SSale | −12.6K | $5.29 | −$66.7K | −3.8%318.6K after | |
| Feb 2, 2026 (view filing) | Feb 2 | Same day | Alvino MarkDirector | SSale | −2.00K | $5.09 | −$10.2K | −2.3%84.1K after | |
| Feb 2, 2026 (view filing) | Feb 2 | Same day | Alland LeilaDirector | SSale | −18.1K | $5.09 | −$92.0K | −9.4%173.6K after | |
| Feb 2, 2026 (view filing) | Feb 2 | Same day | Crombez EricDirector | SSale | −16.3K | $5.09 | −$82.9K | −20.4%63.5K after | |
| Feb 2, 2026 (view filing) | Feb 2 | Same day | Wuchterl Donald A.Director | SSale | −14.8K | $5.09 | −$75.4K | −8.1%167.9K after | |
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Silverstein Christine BerniDirector | SSale | −20.1K | $5.09 | −$102.2K | −12.7%137.7K after | |
| Mar 16, 2026 (view filing) | Mar 16 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −785 | $4.76 | −$3.74K | −0.1%567.8K after | |
| Mar 31, 2026 (view filing) | Mar 31 | Same day | Seshadri VishwasChief Executive Officer | SSale | −30.0K | $4.38 | −$131.3K | −2.1%1.43M after | 10b5-1 |
| May 11, 2026 (view filing) | May 11 | Same day | Vasanthavada MadhavChief Commercial Officer | SSale | −5.55K | $5.96 | −$33.1K | −1.7%313.1K after | |
| May 15, 2026 (view filing) | May 15 | Same day | Crombez EricDirector | SSale | −26.1K | $5.53 | −$144.6K | −41.2%37.3K after | 10b5-1 |
| May 22, 2026 (view filing) | May 22 | Same day | Alvino MarkDirector | SSale | −6.50K | $5.46 | −$35.5K | −7.7%77.6K after | |
| Jun 9, 2026 (view filing) | Jun 8-9 | 1 day | O'Malley Brendan M.SVP, Chief Legal Officer | SSale | −11.1K | $5.36 | −$59.6K | −2.5%440.0K after | 2 lots |
| Jun 9, 2026 (view filing) | Jun 8-9 | 1 day | Seshadri VishwasChief Executive Officer | SSale | −56.3K | $5.36 | −$301.8K | −3.9%1.37M after | 2 lots |
| Jun 9, 2026 (view filing) | Jun 8-9 | 1 day | Vasanthavada MadhavChief Commercial Officer | SSale | −9.62K | $5.36 | −$51.5K | −3.1%303.5K after | 2 lots |
| Jun 9, 2026 (view filing) | Jun 8-9 | 1 day | Vazzano Joseph WalterChief Financial Officer | SSale | −49.3K | $5.37 | −$265.1K | −8.7%518.4K after | 3 lots10b5-1 |
| Jun 15, 2026 (view filing) | Jun 15 | Same day | Silverstein Christine BerniDirector | SSale | −18.2K | $5.71 | −$103.7K | −13.2%119.6K after | |
| Jul 2, 2026 (view filing)4:30 PM ET | Jun 30 | 2 days | Alland LeilaDirector | SSale | −11.0K | $5.92 | −$65.1K | −6.3%162.6K after | |
| Jul 9, 2026 (view filing)7:17 PM ET | Jul 9 | Same day | Vasanthavada MadhavChief Commercial Officer | SSale | −12.6K | $6.96 | −$87.8K | −4.2%290.6K after | |
| Jul 9, 2026 (view filing)7:20 PM ET | Jul 9 | Same day | O'Malley Brendan M.SVP, Chief Legal Officer | SSale | −12.1K | $6.96 | −$83.9K | −2.7%428.0K after | |
| Jul 9, 2026 (view filing)7:22 PM ET | Jul 9 | Same day | Seshadri VishwasChief Executive Officer | SSale | −68.0K | $6.96 | −$473.3K | −4.9%1.31M after | |
| Jul 9, 2026 (view filing)7:24 PM ET | Jul 9 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −24.9K | $6.96 | −$173.3K | −4.8%493.6K after | |
| Jul 22, 2026 (view filing)4:30 PM ET | Jul 21 | 1 day | Vazzano Joseph WalterChief Financial Officer | SSale | −1.48K | $6.53 | −$9.65K | −0.3%492.1K after | |
| Sep 1, 2026 (view filing)5:48 PM ET | Sep 1 | Same day | Alvino MarkDirector | SSale | −15.0K | $5.86 | −$88.0K | −19.5%62.1K after |